| Name | Number of Reports | Reference(s) | Data Source | |
|---|---|---|---|---|
| 1 | Dabigatran | FAERS: 4 | US FAERS | |
| 2 | Everolimus | FAERS: 2 | US FAERS | |
| 3 | Sitagliptin Phosphate | FAERS: 2 | US FAERS | |
| 4 | Ketamine | FAERS: 1 | US FAERS | |
| 5 | Liraglutide | FAERS: 1 | US FAERS | |
| 6 | Olmesartan Medoxomil | FAERS: 1 | US FAERS | |
| 7 | Pamidronate | FAERS: 1 | US FAERS | |
| 8 | Phenelzine | FAERS: 1 | US FAERS | |
| 9 | Rivaroxaban | FAERS: 1 | US FAERS | |
| 10 | Tamsulosin | FAERS: 1 | US FAERS | |
| 11 | Warfarin | FAERS: 1 | US FAERS | |
| 12 | bicalutamide | FAERS: 1 | US FAERS | |
| 13 | Acyclovir | OFFSIDES | ||
| 14 | Cortisone | OFFSIDES | ||
| 15 | Pamidronate | OFFSIDES | ||
| 16 | Prazepam | OFFSIDES | ||
| 17 | Prednisone | OFFSIDES | ||
| 18 | Ribavirin | OFFSIDES | ||
| 19 | isosorbide-5-mononitrate | SIDER |
Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120265
Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.